Detail

Study ID: COG AALL1331

Title:

Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC# 765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

Location:
Principal Investigator:
Disease:
ALL (Acute Lymphocytic Leukemia)
Stage:
Phase III
Status:
Active - Open to Accrual